Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Androidâ„¢ device!
Free
Faster access than browser!
 

AD-1211

Index AD-1211

AD-1211 is an opioid analgesic drug invented in the 1970s by Dainippon Pharmaceutical Co. [1]

17 relations: Agonist-antagonist, AH-7921, Analgesic, Diphenidine, Drug tolerance, Ephenidine, Fluorolintane, Lanicemine, Lefetamine, Methoxphenidine, MT-45, Opioid, Pentazocine, Piperazine, Prenylation, Remacemide, Substance dependence.

Agonist-antagonist

In pharmacology the term agonist-antagonist or mixed agonist/antagonist is used to refer to a drug which under some conditions behaves as an agonist (a substance that fully activates the receptor that it binds to) while under other conditions, behaves as an antagonist (a substance that binds to a receptor but does not activate and can block the activity of other agonists).

New!!: AD-1211 and Agonist-antagonist · See more »

AH-7921

AH-7921 is an opioid analgesic drug selective for the µ-opioid receptor, having around 90% the potency of morphine when administered orally.

New!!: AD-1211 and AH-7921 · See more »

Analgesic

An analgesic or painkiller is any member of the group of drugs used to achieve analgesia, relief from pain.

New!!: AD-1211 and Analgesic · See more »

Diphenidine

Diphenidine (1,2-DEP, DPD, DND) is a dissociative anesthetic that has been sold as a designer drug.

New!!: AD-1211 and Diphenidine · See more »

Drug tolerance

Drug tolerance is a pharmacological concept describing subjects' reduced reaction to a drug following its repeated use.

New!!: AD-1211 and Drug tolerance · See more »

Ephenidine

Ephenidine (also known as NEDPA and EPE) is a dissociative anesthetic that has been sold online as a designer drug.

New!!: AD-1211 and Ephenidine · See more »

Fluorolintane

Fluorolintane (also known as 2-FPPP) is a dissociative anesthetic drug that has been sold online as a designer drug.

New!!: AD-1211 and Fluorolintane · See more »

Lanicemine

Lanicemine (AZD6765) is a low-trapping NMDA receptor antagonist that was under development by AstraZeneca for the management of severe and treatment-resistant depression.

New!!: AD-1211 and Lanicemine · See more »

Lefetamine

Lefetamine (Santenol) is a drug which is a stimulant and also an analgesic with effects comparable to codeine.

New!!: AD-1211 and Lefetamine · See more »

Methoxphenidine

Methoxphenidine (methoxydiphenidine, 2-MeO-Diphenidine, MXP) is a dissociative of the diarylethylamine class that has been sold online as a designer drug.

New!!: AD-1211 and Methoxphenidine · See more »

MT-45

MT-45 (IC-6) is an opioid analgesic drug invented in the 1970s by Dainippon Pharmaceutical Co. It is chemically a 1-substituted-4-(1,2-diphenylethyl)piperazine derivative, which is structurally unrelated to most other opioid drugs.

New!!: AD-1211 and MT-45 · See more »

Opioid

Opioids are substances that act on opioid receptors to produce morphine-like effects.

New!!: AD-1211 and Opioid · See more »

Pentazocine

Pentazocine, sold under the brand name Talwin among others, is a painkiller used to treat moderate to severe pain.

New!!: AD-1211 and Pentazocine · See more »

Piperazine

Piperazine is an organic compound that consists of a six-membered ring containing two nitrogen atoms at opposite positions in the ring.

New!!: AD-1211 and Piperazine · See more »

Prenylation

Prenylation (also known as isoprenylation or lipidation) is the addition of hydrophobic molecules to a protein or chemical compound.

New!!: AD-1211 and Prenylation · See more »

Remacemide

Remacemide is a drug which acts as a low-affinity NMDA antagonist with sodium channel blocking properties.

New!!: AD-1211 and Remacemide · See more »

Substance dependence

Substance dependence also known as drug dependence is an adaptive state that develops from repeated drug administration, and which results in withdrawal upon cessation of drug use.

New!!: AD-1211 and Substance dependence · See more »

References

[1] https://en.wikipedia.org/wiki/AD-1211

OutgoingIncoming
Hey! We are on Facebook now! »